Submitted:
26 May 2026
Posted:
28 May 2026
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Chemicals
2.2. Synthesis
2.3. Biological Assays
2.3.1. In Vitro Antibacterial Activity
2.3.2. Anticancer Activity
2.4. Computational Studies
2.4.1. DFT Studies
2.4.2. Molecular Docking Studies
3. Results and Discussion
3.1. Analytical Studies
3.2. Pharmacological Studies
3.2.1. Antibacterial Activity
3.3. Computational Studies
3.3.1. DFT Studies
3.3.2. Molecular Docking
3.4. ADMET Analysis
4. Conclusions
Acknowledgments
Conflicts of Interest
Abbreviations
References
- Singh, D.P.; Kumar, R.; Kamboj, M.; Jain, K. Synthesis, Spectral, and Antibacterial Studies of 16-Membered Tetraazamacrocyclic Complexes. J. Coord. Chem. 2009, 62, 2995–3002. [Google Scholar] [CrossRef]
- Kishore, R.; Kamboj, M.; Shukla, M.; Chaturvedi, D.; Srivastava, N. Novel strategy for synthesis of cyclic dithiocarbamates catalyzed by Triton B. Asian J. Chem. 2019, 31(5), 1091–1094. [Google Scholar] [CrossRef]
- Kishore, R.; Kamboj, M.; Shukla, M.; Chaturvedi, D. Triton-B mediated efficient synthesis of thioxoimidazolidine-4,5-diones. Asian J. Chem. 2020, 32(1), 183–186. [Google Scholar] [CrossRef]
- Kishore, R.; Kamboj, M.; Shukla, M. Triton-B Mediated One-Pot Multicomponent Synthesis of 3,5 Substituted Tetrahydro-2H-1,3,5-Thidiazine-2-Thiones. Orient. J. Chem. 2018, 34(6), 2878–2883. [Google Scholar] [CrossRef]
- Waziri, I.; Nthehang, T.S.; Oyedeji-Amusa, M.O.; Oyebamiji, A.K.; Adeyinka, A.S.; Muller, A.A. Chem. Sel. 2025, 10(35), e01578. [CrossRef]
- Chandra, S.; Gupta, L.K.; Agrawal, S. Modern spectroscopic and biological approach in the characterization of a novel 14-membered [N4] macrocyclic ligand and its transition metal complexes. Trans. Met. Chem. 2007, 32, 240–245. [Google Scholar] [CrossRef]
- Tusek-Bozic, L.; Marotta, E.; Traldi, P. Efficient solid-state microwave-promoted complexation of a mixed dioxa-diaza macrocycle with an alkali salt. Synthesis of a sodium ethyl 4-benzeneazophosphonate complex. Polyhedron 2007, 26, 1663–1668. [Google Scholar] [CrossRef]
- Chandra, S.; Gupta, R.; Gupta, N.; Bawa, S.S. Biologically Relevant Macrocyclic Complexes of Copper Spectral, Magnetic, Thermal and Antibacterial Approach. Trans. Met. Chem. 2006, 31, 147–151. [Google Scholar] [CrossRef]
- Curtis, N.F. Macrocyclic coordination compounds formed by condensation of metal-amine complexes with aliphatic carbonyl compounds. Coord. Chem. Rev. 1968, 3, 3–47. [Google Scholar] [CrossRef]
- Niasari, M.S.; Daver, F. In situ one-pot template synthesis (IOPTS) and characterization of copper (II) complexes of 14-membered hexaaza macrocyclic ligand 3,10-dialkyl-dibenzo-1,3,5,8,10,12-hexaazacyclotetradecane. Inorg. Chem. Commun. 2006, 9(2), 175–179. [Google Scholar] [CrossRef]
- Lozovan, V.; Kravtsov, V.; Bulhac, I.; Petuhov, O.; Vlase, T.; Bourosh, P. N. Tetraaza macrocyclic complexes of Cu(II), Co(III) and Ni(II) derived from template condensation of 2,6-pyridinedicarbohydrazide and 2,6-diacetylpyridine: Stability investigation and coloring properties on plastics. J. Mol. Str. 2025, 1321(3), 140021. [Google Scholar] [CrossRef]
- Hanaa, E.; Ohyla, E. Novel (N) Macrocyclic Metal Complexes: Synthesis, Characterization, Spectral Studies and Anticancer Activity. Open Chem. J. 2018, 5, 51–63. [Google Scholar] [CrossRef]
- Subhash; Chaudhary, A.; Jyoti; Kumar, M.; Mamta; Solanki, R. Synthesis, structural elucidation, DFT investigations, biological evaluation and molecular docking studies of tetraamide-based macrocyclic cobalt (II) complexes. J. Iran. Chem. Soc. 2023, 20, 2339–2362. [Google Scholar] [CrossRef]
- Chandra, S.; Pundir, M. Spectroscopic characterization of chromium(III), manganese(II) and nickel(II) complexes with a nitrogen donor tetradentate, 12-membered azamacrocyclic ligand. Spectrochim. Acta A. 2008, 69, 1–7. [Google Scholar] [CrossRef]
- Shubash; Kumar, M.; Devi, A.; Chaudhary, A. Novel amide-based macrocyclic Co(ii) complexes: correlating structural, computational, and biological properties through DFT and docking. RSC Adv. 2026, 16, 3169–3191. [Google Scholar] [CrossRef]
- Singh, D.P.; Kumar, R.; Kamboj, M.; Grover, V.; Jain, K. Template Synthesis and Characterization of N6 12-Membered Macrocyclic Complexes Derived from Isatin and Ethylenediamine. Russ. J. Coord. Chem. 2008, 34, 233–235. [Google Scholar] [CrossRef]
- Singh, D.P.; Kamboj, M.; Kumar, K.; Jain, K.; Sharma, C.; Aneja, K.R. Synthesis, Spectroscopic Studies and Biological Screening of 18-Membered Octaazamacrocyclic Complexes Derived from Acetonylacetone and Thiocarbohydrazide. Russ. J. Inorg. Chem. 2011, 56, 1396–1401. [Google Scholar] [CrossRef]
- Mamta; Chaudhary, A. Synthesis, spectroscopic characterization, in vitro antimicrobial activity, antioxidant study, and theoretical approaches towards DNA gyrase, DHFR enzyme, NADPH enzyme of N8-tetraoxomacrocyclic complexes of Zn(II). J. Mol. Struct. 2024, 1295, 136743. [Google Scholar] [CrossRef]
- Godoy-Gallardo, M.; Eckhard, U.; Delgado, L. M.; de Roo Puente, Y.J.D.; Hoyos-Nogués, M.; Gil, F.J.; Perez, R.A. Antibacterial approaches in tissue engineering using metal ions and nanoparticles: From mechanisms to applications. Bioact. Mater. 2021, 6, 4470–4490. [Google Scholar] [CrossRef] [PubMed]
- Abendrot, M.; Chęcińska, L.; Kusz, J.; Lisowska, K.; Zawadzka, K.; Felczak, A.; Kalinowska-Lis, U. Zinc(II) Complexes with Amino Acids for Potential Use in Dermatology: Synthesis, Crystal Structures, and Antibacterial Activity. Molecules 2020, 25, 951. [Google Scholar] [CrossRef] [PubMed]
- Vogel, A.I. A textbook of quantitative chemical analysis; Longman, London, 1989. [Google Scholar]
- Andrews, J.M. Determination of minimum inhibitory concentrations. J. Antimicrob. Chemother. 2001, 48, 5–16. [Google Scholar] [CrossRef] [PubMed]
- Kamboj, M.; Singh, D.P.; Singh, A.K.; Chaturvedi, D. Molecular Modeling, in-Silico Docking and Antibacterial Studies of Novel Template Wangled Macrocyclic Complexes Involving Isatin Moiety. J. Mol. Struct. 2020, 1207, https://doi.org/10.1016/j.molstruc.2019.127602; Kamboj, M.; Jain, K.; Singh, D.P. Template Engineered Tetraazamacrocyclic Complexes and Their Antibacterial Studies. In Asian Journal of Chemistry; 2018; Volume 30, pp. 1431–1434. [Google Scholar] [CrossRef]
- Ahmad, I.; Beg, A.J. Antimicrobial and phytochemical studies on 45 Indian medicinal plants against multi-drug-resistant human pathogens. J. Ethnopharmacol. 2001, 74, 113–123. [Google Scholar] [CrossRef]
- Srivastava, N.; Kishore, R. Cleaner, Greener Synthesis, Characterization, and Anticancer Evaluation of 2-Thioxo-1,3- Thiazolanes. Indian J. Heterocycl. Chem. 2021, 31, 265–271. Available online: https://connectjournals.com/01951.2021.31.265.
- Roy, A. K. A new density functional method for electronic structure calculation of atoms and molecules. physics.chem-ph. 2019. Available online: https://arxiv.org/abs/1904.08806.
- Perdew, J.P.; Burke, K.; Ernzerhof, M. Generalized Gradient Approximation Made Simple. In Phys. Rev. Lett.;Phys. Rev. Lett.; Perdew, J.P., Burke, K., Ernzerhof, M., Eds.; 1996; Volume 78, p. 1396. [Google Scholar] [CrossRef]
- Giannozzi, P.; Baroni, S.; Bonini, N.; et al. QUANTUM ESPRESSO: a modular and open-source software project for quantum simulations of materials. J. Phys. Condens. Matter. 2009, 28 21, 395502. [Google Scholar] [CrossRef]
- Laasonen, K.; Car, R.; Lee, C.; Vanderbilt, D. Implementation of ultrasoft pseudopotentials in ab initio molecular dynamics. Phys. Rev. B. 1991, 43, 6796. [Google Scholar] [CrossRef]
- Hellmann, H. Einführung in die Quantenchemie. Leipzig: Franz Deuticke. p. 285. Feynman, R. P. 1939. “Forces in Molecules”. Physical Review 1939, 56, 340–343. [Google Scholar]
- Rasul, H.O.; Ghafour, D.D.; Aziz, B.K.; Hassan, B.A.; Rashid, T.A.; Kivrak, A. Decoding Drug Discovery: Exploring A-to-Z In Silico Methods for Beginners. Appl. Biochem. Biotechnol. 2025, 197(3), 1453–1503. [Google Scholar] [CrossRef]
- Huang, C.; Wei, L.; Yuan, W.; Lu, Y.; Zhang, G.; Yan, Z. Molecular Mechanisms of Aspartame-Induced Kidney Renal Papillary Cell Carcinoma Revealed by Network Toxicology and Molecular Docking Techniques. Int. J. Mol. Sci. 2026, 27(1), 77. [Google Scholar] [CrossRef] [PubMed]
- Martins, F.G.; Santos, H.A.; Sousa, S.F. A Review of Current Computational Tools for Peptide–Protein Docking, J. Comput. Chem. 2026, 47(5), e70328. [Google Scholar] [CrossRef]
- de Angelo, R.M.; de Sousa, D. S.; da Silva, A.P.; Chiari, L.P.>A.; da Silva, A.B.F.; Honório, K.M. Molecular Docking: State-of-the-Art Scoring Functions and Search Algorithms. In book: Computer-Aided and Machine Learning-Driven Drug Design; Maltarollo, V.G., Ed.; Springer Nature Switzerland: Cham, Switzerland, 2024. [Google Scholar] [CrossRef]
- Kiouri, D. P.; Batsis, G. C.; Chasapis, C. T. Structure-Based Approaches for Protein–Protein Interaction Prediction Using Machine Learning and Deep Learning. Biomol. 2025, 15(1), 141. [Google Scholar] [CrossRef] [PubMed]
- Singh, S.; Kumar, S.; Quadir, S.S.; Bhandari, S.; Baniya, B.; Joshi, G.; Jain, C.P.; Choudhary, D. Artificial Intelligence: Preface, Applications and Future Perspective in Relation to Pharmaceutical Sector. J. Pharm. Innov. 2025, 20, 39. [Google Scholar] [CrossRef]
- Robin, X.; Škrinjar, P.; Waterhouse, A.M.; Studer, G.; Tauriello, G.; Durairaj, J.; Schwede, T. Beyond Single Chains: Benchmarking Macromolecular Complex Prediction Methods With the Continuous Automated Model EvaluatiOn ( CAMEO ). Proteins Struct. Funct. Genet. 2026, 94(1), 403–413. [Google Scholar] [CrossRef]
- Singh, D.P.; Kumar, R.; Kamboj, M.; Jain, K. Biologically Active Tetraazamacrocyclic Complexes of Co(II), Ni(II), Cu(II) and Zn(II). Acta Chim. Slov. 2009, 56, 780–785. [Google Scholar]
- Siddiqi, Z.A.; Khan, M.M.; Khalid, M.; Kumar, S. Spectral and electrochemical characterization of bimetallic complexes of a novel 32-membered unsymmetrical [N12] macrocycle. Transit. Met. Chem. 2007, 32, 927–935. [Google Scholar] [CrossRef]
- Tyagi, P.; Chandra, S.; Saraswat, B.S.; Sharma, D. Design, spectral characterization, DFT and biological studies of transition metal complexes of Schiff base derived from 2-aminobenzamide, pyrrole and furan aldehyde. Spectrochim. Acta A. 2015, 43, 1–11. [Google Scholar] [CrossRef]
- Kamboj, D.P.; Kumar, M.; Jain, K.; Sharma, K.C. Divalent Metal Macrocyclic Complexes Derived from Acetonylacetone and Carbohydrazide with Their Spectroscopic and Antibacterial Studies. J. Coord. Chem. 2011, 64, 502–510. [Google Scholar] [CrossRef]
- Kumar, K.; Kamboj, M.; Jain, K.; Singh, D.P. Spectroscopic and Antibacterial Studies of New Octaazamacrocyclic Complexes Derived from Carbohydrazide and Isatin. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2014, 128, 243–247. [Google Scholar] [CrossRef] [PubMed]
- Arivazhagan, M.; Manivel, S.; Jeyavijayan, S.; Meenakshi, R. Vibrational spectroscopic (FTIR and FT-Raman), first-order hyperpolarizability, HOMO, LUMO, NBO, Mulliken charge analyses of 2-ethylimidazole based on Hartree–Fock and DFT calculations. Spectrochim. Acta A. 2015, 134, 493–501. [Google Scholar] [CrossRef] [PubMed]
- Al – Saadawy, N. Synthesis, Characterization, and Theoretical Study of Some New Organotellurium Compounds Derived from Camphor. Indones. J. Chem. 2022, 22, 437–448. [Google Scholar] [CrossRef]
- Scheinmann, F. An Introduction to Spectroscopic Methods for the Identification of Organic Compounds: Mass Spectrometry, Ultraviolet Spectroscopy, Electron Spin Resonance Spectroscopy, Nuclear Magnetic Resonance Spectroscopy (Recent Developments), Use of Various Spectral Methods Together, and Documentation of Molecular Spectra; Elsevier Science: Amsterdam, Netherlands, 2014. [Google Scholar]
- Raen, R.; Islam, M. M.; Islam, R.; Islam, M.R.; Jarin, T. Functional characterization and structural prediction of hypothetical proteins in monkeypox virus and identification of potential inhibitors. Mol. Divers. 2025, 29(2), 1589–1617. [Google Scholar] [CrossRef]
- Daina, A.; Michielin, O.; Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 2017, 3(7), M42717. [Google Scholar] [CrossRef] [PubMed]
- Pires, D.E.; Blundell, T.L.; Ascher, D.B. pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures. J. Med. Chem. 2015, 58(9), 4066–72. [Google Scholar] [CrossRef] [PubMed]
- Daina, A.; Michielin, O.; Zoete, V. iLOGP: a simple, robust, and efficient description of n-octanol/water partition coefficient for drug design using the GB/SA approach. J. Chem. Inf. Model. 2014, 54(12), 3284–301. [Google Scholar] [CrossRef] [PubMed]






![]() |
| S.No. | Bacterial Strain |
Diameter of zone of inhibition, mm | ||||
|---|---|---|---|---|---|---|
| Concentration (mg/mL) |
Gentamycin (Standard) (mm) |
Control (DMSO) | ||||
| 50 |
75 |
100 |
50 mg/mL |
50% | ||
| ZnMc1 |
Bacillus subtilis (Gram-positive) |
0 | 1 | 1.2 | 2.8 | 0 |
| ZnMc2 | 0 | 1.1 | 1.1 | 2.8 | 0 | |
| ZnMc3 | 0 | 1.3 | 1.5 | 2.8 | ||
| S.No | Concentration(μg/mL) | Cytotoxicity % | ||
|---|---|---|---|---|
| A | C | D | ||
| 1. | 48 | 39.22 | 21.57 | 9.48 |
| 2. | 24 | 33.68 | 14.35 | 2.51 |
| 3. | 12 | 27.07 | 5.19 | 1.78 |
| 4. | 6 | 20.95 | 2.21 | 1.03 |
| 5. | 3 | 10.61 | 1.01 | 0.76 |
| 6. | 1.5 | 2.02 | 0.43 | 0.28 |
| Molecule | EHOMO (eV) | EFERMI (eV) | ELUMO (eV) | E.A (eV) | I.P (eV) | X = (EHOMO +ELUMO)/2 (eV) | Eg= (EHOMO -ELUMO) (eV) | Total Energy (eV) |
|---|---|---|---|---|---|---|---|---|
| ZnMc1 | -4.8266 | -4.0393 | -2.8770 | -2.8770 | 4.8266 | -3.8518 | 1.9496 | -990.73591 |
| ZnMc 2 | -6.5898 | -5.0874 | -3.7995 | -3.7995 | 6.5898 | -5.1947 | 2.7903 | -885.33233 |
| ZnMc3 | -6.4932 | -5.0798 | -3.5538 | -3.5538 | 6.4932 | -5.0235 | 2.9394 | -843.65217 |
| Molecule/Bond | Zn-Cl | C-N | C-H | C-O | N-H | C-C | N-Zn | Energy/atom (Ry) |
|---|---|---|---|---|---|---|---|---|
| ZnMc1 | 2.231(2.214) | 1.436 (1.397) | 1.090 | 1.217 (1.212) | 1.020 | 1.636 (1.403) | 3.612 (2.909) | -25.4034849 |
| ZnMc2 | 3.375 (2.168) | 1.484 (1.415) | 1.100 (1.099) | 1.215 (1.211) | 1.055 (1.029) | 1.569 (1.534) | 2.385 (2.155) | -23.9279009 |
| ZnMc3 | 3.727 (2.163) | 1.489 (1.404) | 1.100 (1.097) | 1.214 (1.205) | 1.099 (1.020) | 1.571 (1.550) | 2.219(2.140) | -27.2145863 |
| Molecule/Bond | Zn-Cl | C-N | C-H | C-O | N-H | C-C | N-Zn | Energy/atom (Ry) |
| ZnMc1 | 2.231(2.214) | 1.436 (1.397) | 1.090 | 1.217 (1.212) | 1.020 | 1.636 (1.403) | 3.612 (2.909) | -25.4034849 |
| ZnMc2 | 3.375 (2.168) | 1.484 (1.415) | 1.100 (1.099) | 1.215 (1.211) | 1.055 (1.029) | 1.569 (1.534) | 2.385 (2.155) | -23.9279009 |
| ZnMc3 | 3.727 (2.163) | 1.489 (1.404) | 1.100 (1.097) | 1.214 (1.205) | 1.099 (1.020) | 1.571 (1.550) | 2.219(2.140) | -27.2145863 |
| Sr.no. | Complex | PDB no | Receptor | Binding Affinity |
|---|---|---|---|---|
| 1. | ZnMc2 |
7AHL | ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS | -5.3 |
| 6COX | CYCLOOXYGENASE-2 (PROSTAGLANDIN SYNTHASE-2) | -6.5 | ||
| 2. | ZnMc3 | 7AHL | ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS | -5.4 |
| 6COX | CYCLOOXYGENASE-2 (PROSTAGLANDIN SYNTHASE-2) | -6.4 |
| Complex | Formula | Mw | HBD | HBA | Nrot | Logp | TPSA | Logs | Csp3 | Leadlikeness |
|---|---|---|---|---|---|---|---|---|---|---|
| Znmc1 | C16H12Cl2N4O4Zn | 460.58 | 4 | 4 | 0 | 1.8093 | 116.40 | -4.59 | 0 | No |
| Znmc2 | C8H12Cl2N4O4Zn | 364.49 | 4 | 4 | 0 | -2.1587 | 116.40 | -1.88 | 0.50 | No |
| Znmc3 | C10H16Cl2N4O4Zn | 392.54 | 4 | 4 | 0 | -1.3785 | 116.40 | -2.5 | 0.6 | No |
| Compound | Lipinski | Ghose | Veber | Egan | Muegge | Bioavailability score | No of Violations |
|---|---|---|---|---|---|---|---|
| ZnMc1 | Yes | Yes | Yes | Yes | Yes | 0.55 | 0 |
| ZnMc2 | Yes | No | Yes | Yes | Yes | 0.55 | 1 |
| ZnMc3 | yes | no | yes | yes | yes | 0.55 | 1 |
| Complex | GI absorption | BBB permeant | P-gp Substrate | CYP1A2 inhibitor | CYP2C19 inhibitor | CYP2C9 inhibitor | CYP2D6 inhibitor | CYP3A4 inhibitor |
|---|---|---|---|---|---|---|---|---|
| ZnMc1 | High | No | Yes | yes | No | No | no | yes |
| ZnMc2 | Low | No | No | No | No | No | No | No |
| ZnMc3 | Low | No | No | No | No | No | No | no |
| Complexes | AMES toxicity | Hepatoxicity | Max. tolerated dose (human) mg/kg/day | Oral rat Acute Toxicity (LD50) |
Oral Rat Chronic Toxicity (LOAEL) (mol/kg) |
T.Pyriformis toxicity (log ug/L) |
hERG I inhibitor | hERG II inhibitor | Skin Sensitisation |
|---|---|---|---|---|---|---|---|---|---|
| 1 | No | No | 0.181 | 2.218 | 1.246 | 0.3 | no | no | no |
| 2 | No | no | 1.087 | 2.929 | 1.83 | 0.144 | no | no | no |
| 3 | No | no | 0.835 | 3.188 | 1.568 | 0.148 | no | no | no |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
